🛡️ Public data only — no PHI permitted on this instance.

HOSP

BETH ISRAEL DEACONESS MEDICAL CENTER

CCN 220086|LOC BOSTON, MA|BEDS 705|NPR $1,674.0M|MARGIN -38.9%

SeekingChartis Score

INVESTMENT THESIS

Buy: BETH ISRAEL DEACONESS MEDICAL CENTE

/ 100 (B)

+$123.2M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$1.67B

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

58%

CATALYSTS

▲RCM uplift of $123.2M (+736bps)

▲Platform-sized facility

RISKS

▼Elevated distress risk (42%)

Buy — solid fundamentals with identifiable value creation levers. Proceed to detailed diligence.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$1,674.0M

Net Patient Revenue

-38.9%

Operating Margin

$-651.3M

Net Income

705

Licensed Beds

$2,375K

Revenue per Bed

$2,325.4M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 31%■ MEDICAID · 9%■ COMMERCIAL · 61%

Score Breakdown

SCComposite · 49/100

Component	Score	Max	%
Market Position	31	35	89%
Financial Health	0	25	0%
Operational Quality	0	20	0%
Competitive Moat	8	20	40%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
220001	HEALTHALLIANCE-CLINTON	125	$0M
220002	MOUNT AUBURN HOSPITAL	186	$0M
220008	STURDY MEMORIAL HOSPITAL	125	$0M
220010	LAWRENCE GENERAL HOSPITAL	186	$0M
220011	CAMBRIDGE HEALTH ALLIANCE	225	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN MAStart Diligence · creates a deal from HCRIS